K M C Speciality Hospitals (India) financials

·Pharma & HealthChart ›

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast closeFY24Mar 2024FY23Mar 2023FY22Mar 2022FY21Mar 2021FY20 and earlierAlpha Plus
2,456————
FY20 and earlierEvery year the company has filed comes with Alpha Plus.
——1.81.72.1
——39.926.925.7
177177156136103
—+13.8%+14.5%+32.6%—
47.447.441.337.223.2
26.8%26.8%26.5%27.3%22.6%
38.238.233.730.617.1
30.430.426.723.712.8
17.2%17.2%17.1%17.4%12.5%
₹1.86₹1.86₹1.63₹1.45₹0.78
—+13.8%+12.5%+85.7%—
38.438.4—29.125.6
38.438.4—29.125.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KMCSHIL₹150.36

K M C Speciality Hospitals (India) Limited

· Pharma & Health
₹ CrorePeersDRAGARWQKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDMcap ₹2,456 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY21
31/03/2021
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Current
last close
Market Capitalization————2,455.8
- Cash, Equiv & ST Investments2.11.71.8——
+ Total Debt25.726.939.9——
Revenue102.6136.1155.8177.2177.2
Growth %, YoY—+32.6+14.5+13.8—
EBITDA23.237.241.347.447.4
Margin %22.6427.3226.5326.7526.75
EBIT17.130.633.738.238.2
Net Income12.823.726.730.430.4
Margin %12.4517.4417.1317.1517.15
EPS, Adj (current shares)0.781.451.631.861.86
Growth %, YoY—+85.7+12.5+13.8—
Cash from Operations25.629.1—38.438.4
Free Cash Flow25.629.1—38.438.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.

K M C Speciality Hospitals financials and key ratios

Figures from the company's filings with NSE

In FY24 its consolidated net profit was ₹30.4 crore on revenue of ₹177 crore.

K M C Speciality Hospitals at a glance · consolidated

Free cash flow (FY24)
₹38.4 Cr
EPS (FY24)
₹1.86

Questions

What is the K M C Speciality Hospitals EPS?

K M C Speciality Hospitals' basic earnings per share (EPS) were ₹1.86 in FY24, against ₹1.64 in FY23.

What is the K M C Speciality Hospitals free cash flow?

In FY24, K M C Speciality Hospitals generated ₹38.4 crore of cash from operations and spent ₹0 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹38.4 crore.

What is the K M C Speciality Hospitals revenue and profit in FY24?

In FY24 (April 2023–March 2024), K M C Speciality Hospitals' consolidated net profit was ₹30.4 crore, up 13.8% from ₹26.7 crore in FY23, on revenue from operations of ₹177 crore (up 13.8%). Over three years, from FY21, net profit was up 137.7%.

Where do these K M C Speciality Hospitals figures come from?

From K M C Speciality Hospitals' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.